These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 9516930
1. Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma. Kuo CT, Bostick PJ, Irie RF, Morton DL, Conrad AJ, Hoon DS. Clin Cancer Res; 1998 Feb; 4(2):411-8. PubMed ID: 9516930 [Abstract] [Full Text] [Related]
2. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS. Cancer Res; 2001 Dec 15; 61(24):8845-50. PubMed ID: 11751407 [Abstract] [Full Text] [Related]
3. Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines. Yamashiro S, Ruan S, Furukawa K, Tai T, Lloyd KO, Shiku H, Furukawa K. Cancer Res; 1993 Nov 15; 53(22):5395-400. PubMed ID: 8221677 [Abstract] [Full Text] [Related]
4. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase. Aoki H, Satoh M, Mitsuzuka K, Ito A, Saito S, Funato T, Endoh M, Takahashi T, Arai Y. FEBS Lett; 2004 Jun 04; 567(2-3):203-8. PubMed ID: 15178323 [Abstract] [Full Text] [Related]
5. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR. Mühlbauer M, Langenbach N, Stolz W, Hein R, Landthaler M, Buettner R, Bosserhoff AK. Clin Cancer Res; 1999 May 04; 5(5):1099-105. PubMed ID: 10353744 [Abstract] [Full Text] [Related]
6. Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer. Chen LC, Brown AB, Cheung IY, Cheung NK, Kris MG, Krug LM. Lung Cancer; 2010 Feb 04; 67(2):216-20. PubMed ID: 19457569 [Abstract] [Full Text] [Related]
7. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Sarantou T, Chi DD, Garrison DA, Conrad AJ, Schmid P, Morton DL, Hoon DS. Cancer Res; 1997 Apr 01; 57(7):1371-6. PubMed ID: 9102226 [Abstract] [Full Text] [Related]
8. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies. Hiraiwa N, Tsuyuoka K, Li YT, Tanaka M, Seno T, Okubo Y, Fukuda Y, Imura H, Kannagi R. Cancer Res; 1990 Sep 01; 50(17):5497-503. PubMed ID: 2167157 [Abstract] [Full Text] [Related]
9. Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR. Cheung IY, Cheung NK. Clin Cancer Res; 2001 Jun 01; 7(6):1698-705. PubMed ID: 11410509 [Abstract] [Full Text] [Related]
10. Tumour microdissemination and survival in metastatic melanoma. Schrader AJ, Probst-Kepper M, Grosse J, Kunter U, Franzke A, Sel S, Atzpodien E, Buer J. Anticancer Res; 2000 Jun 01; 20(5B):3619-24. PubMed ID: 11131671 [Abstract] [Full Text] [Related]
11. Localization of UDP-GalNAc:NeuAc alpha 2,3Gal-R beta 1,4(GalNAc to Gal)N-acetylgalactosaminyltransferase in human stomach. Enzymatic synthesis of a fundic gland-specific ganglioside and GM2. Dohi T, Hanai N, Yamaguchi K, Oshima M. J Biol Chem; 1991 Dec 15; 266(35):24038-43. PubMed ID: 1748676 [Abstract] [Full Text] [Related]
12. Analysis of melanoma cells stably transfected with beta 1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression. Ruan S, Raj BK, Furukawa K, Lloyd KO. Arch Biochem Biophys; 1995 Oct 20; 323(1):11-8. PubMed ID: 7487055 [Abstract] [Full Text] [Related]
13. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ, van Muijen GN. Br J Cancer; 1999 Nov 20; 81(5):774-82. PubMed ID: 10555745 [Abstract] [Full Text] [Related]
14. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction. Carrillo E, Marchal JA, Prados J, Melguizo C, Vélez C, Arena N, Alvarez L, Serrano S, Aránega A. Cell Mol Biol (Noisy-le-grand); 1998 Dec 20; 44(8):1247-52. PubMed ID: 9874512 [Abstract] [Full Text] [Related]
15. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance]. Yang SZ, Dong JH, Zhu J, Li K, Zhang Y. Zhonghua Wai Ke Za Zhi; 2004 Sep 07; 42(17):1060-3. PubMed ID: 15498320 [Abstract] [Full Text] [Related]
16. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H, Landthaler M, McClelland M. Clin Cancer Res; 1998 Mar 07; 4(3):791-7. PubMed ID: 9533549 [Abstract] [Full Text] [Related]
17. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method. de Vries TJ, Fourkour A, Punt CJ, Ruiter DJ, van Muijen GN. Melanoma Res; 2000 Apr 07; 10(2):119-26. PubMed ID: 10803712 [Abstract] [Full Text] [Related]
18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN. J Pathol; 2000 Jul 07; 191(3):245-56. PubMed ID: 10878545 [Abstract] [Full Text] [Related]